295 related articles for article (PubMed ID: 25576687)
1. Metoclopramide Nasal Spray Reduces Symptoms of Gastroparesis in Women, but not Men, With Diabetes: Results of a Phase 2B Randomized Study.
Parkman HP; Carlson MR; Gonyer D
Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1256-1263.e1. PubMed ID: 25576687
[TBL] [Abstract][Full Text] [Related]
2. Metoclopramide nasal spray is effective in symptoms of gastroparesis in diabetics compared to conventional oral tablet.
Parkman HP; Carlson MR; Gonyer D
Neurogastroenterol Motil; 2014 Apr; 26(4):521-8. PubMed ID: 24372829
[TBL] [Abstract][Full Text] [Related]
3. Metoclopramide Nasal Spray in Women with Symptomatic Diabetic Gastroparesis: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
McCallum RW; Parkman HP; Fass R; Bhandari BR; Carlson MR; Buck RD
Clin Gastroenterol Hepatol; 2023 Nov; ():. PubMed ID: 37924856
[TBL] [Abstract][Full Text] [Related]
4. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis.
Patterson D; Abell T; Rothstein R; Koch K; Barnett J
Am J Gastroenterol; 1999 May; 94(5):1230-4. PubMed ID: 10235199
[TBL] [Abstract][Full Text] [Related]
5. Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis.
Lembo A; Camilleri M; McCallum R; Sastre R; Breton C; Spence S; White J; Currie M; Gottesdiener K; Stoner E;
Gastroenterology; 2016 Jul; 151(1):87-96.e6. PubMed ID: 27055601
[TBL] [Abstract][Full Text] [Related]
6. Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis.
McCallum RW; Lembo A; Esfandyari T; Bhandari BR; Ejskjaer N; Cosentino C; Helton N; Mondou E; Quinn J; Rousseau F;
Neurogastroenterol Motil; 2013 Nov; 25(11):e705-17. PubMed ID: 23848826
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.
Camilleri M; McCallum RW; Tack J; Spence SC; Gottesdiener K; Fiedorek FT
Gastroenterology; 2017 Nov; 153(5):1240-1250.e2. PubMed ID: 28760384
[TBL] [Abstract][Full Text] [Related]
8. A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis.
Ejskjaer N; Wo JM; Esfandyari T; Mazen Jamal M; Dimcevski G; Tarnow L; Malik RA; Hellström PM; Mondou E; Quinn J; Rousseau F; McCallum RW
Neurogastroenterol Motil; 2013 Feb; 25(2):e140-50. PubMed ID: 23279217
[TBL] [Abstract][Full Text] [Related]
9. Metoclopramide nasal spray for management of symptoms of acute and recurrent diabetic gastroparesis in adults.
Gajendran M; Sarosiek I; McCallum R
Expert Rev Endocrinol Metab; 2021 Mar; 16(2):25-35. PubMed ID: 33739209
[No Abstract] [Full Text] [Related]
10. Is metoclopramide nasal spray an acceptable alternative to its oral form?
Lankarani K
Neurogastroenterol Motil; 2014 Jun; 26(6):885. PubMed ID: 24860969
[No Abstract] [Full Text] [Related]
11. Response to Dr. Lankarani.
Parkman H; Carlson M; Gonyer D
Neurogastroenterol Motil; 2014 Jun; 26(6):886. PubMed ID: 24860970
[No Abstract] [Full Text] [Related]
12. Efficacy and Safety of Tradipitant in Patients With Diabetic and Idiopathic Gastroparesis in a Randomized, Placebo-Controlled Trial.
Carlin JL; Lieberman VR; Dahal A; Keefe MS; Xiao C; Birznieks G; Abell TL; Lembo A; Parkman HP; Polymeropoulos MH
Gastroenterology; 2021 Jan; 160(1):76-87.e4. PubMed ID: 32693185
[TBL] [Abstract][Full Text] [Related]
13. Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis.
Tack J; Rotondo A; Meulemans A; Thielemans L; Cools M
Neurogastroenterol Motil; 2016 Apr; 28(4):487-97. PubMed ID: 27010235
[TBL] [Abstract][Full Text] [Related]
14. Effect of metoclopramide in diabetic gastroparesis.
Ricci DA; Saltzman MB; Meyer C; Callachan C; McCallum RW
J Clin Gastroenterol; 1985 Feb; 7(1):25-32. PubMed ID: 3884697
[TBL] [Abstract][Full Text] [Related]
15. Metoclopramide therapy in fifty-five patients with delayed gastric emptying.
Perkel MS; Hersh T; Moore C; Davidson ED
Am J Gastroenterol; 1980 Sep; 74(3):231-6. PubMed ID: 7468558
[TBL] [Abstract][Full Text] [Related]
16. The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus.
Shin A; Camilleri M; Busciglio I; Burton D; Smith SA; Vella A; Ryks M; Rhoten D; Zinsmeister AR
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1453-1459.e4. PubMed ID: 23639598
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis.
Banov CH; Lieberman P;
Ann Allergy Asthma Immunol; 2001 Jan; 86(1):28-35. PubMed ID: 11206234
[TBL] [Abstract][Full Text] [Related]
18. Gastroparesis following bone marrow transplantation.
Eagle DA; Gian V; Lauwers GY; Manivel JC; Moreb JS; Mastin S; Wingard JR
Bone Marrow Transplant; 2001 Jul; 28(1):59-62. PubMed ID: 11498745
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients.
Hardy J; Daly S; McQuade B; Albertsson M; Chimontsi-Kypriou V; Stathopoulos P; Curtis P
Support Care Cancer; 2002 Apr; 10(3):231-6. PubMed ID: 11904788
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
Jacobs R; Martin B; Hampel F; Toler W; Ellsworth A; Philpot E
Curr Med Res Opin; 2009 Jun; 25(6):1393-401. PubMed ID: 19419338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
